Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FLAME: a model for duration-dependent risk accumulation in episodic temporal exposures.

Biometrics·2026
Same author

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
Same author

Low cardiac index during periods of arterial hypotension and risk of acute kidney injury in cardiac surgery.

British journal of anaesthesia·2026
Same author

Association of postoperative delirium with haemodynamic determinants of cerebral perfusion pressure during cardiac surgery: a retrospective cohort study.

British journal of anaesthesia·2026
Same author

Exploring Links between Brain Image-Derived Phenotypes and Accelerometer-Measured Physical Activity in the UK Biobank.

bioRxiv : the preprint server for biology·2026
Same author

Fast Bayesian Functional Principal Components Analysis.

Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America·2026

Related Experiment Video

Updated: May 25, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Mixed effect Poisson log-linear models for clinical and epidemiological sleep hypnogram data.

Bruce J Swihart1, Brian S Caffo, Ciprian M Crainiceanu

  • 1Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. bswihart@jhsph.edu

Statistics in Medicine
|January 14, 2012
PubMed
Summary

New Bayesian models analyze sleep transition rates in large populations, accounting for individual differences and disease status. This approach improves understanding of sleep variability using advanced statistical methods for epidemiological studies.

More Related Videos

IntelliSleepScorer, a Software Package with a Graphic User Interface for Mice Automated Sleep Stage Scoring
04:54

IntelliSleepScorer, a Software Package with a Graphic User Interface for Mice Automated Sleep Stage Scoring

Published on: November 8, 2024

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

Related Experiment Videos

Last Updated: May 25, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

IntelliSleepScorer, a Software Package with a Graphic User Interface for Mice Automated Sleep Stage Scoring
04:54

IntelliSleepScorer, a Software Package with a Graphic User Interface for Mice Automated Sleep Stage Scoring

Published on: November 8, 2024

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

Area of Science:

  • Biostatistics
  • Epidemiology
  • Sleep Science

Background:

  • Sleep state transitions are crucial for understanding sleep quality and disorders.
  • Existing statistical models for sleep transition data have limitations in scalability and handling complex hierarchical structures.
  • Accurate analysis is vital for comparing disease and non-disease groups while minimizing bias.

Purpose of the Study:

  • To propose scalable Bayesian Poisson log-linear multilevel models for analyzing population variability in sleep state transition rates.
  • To provide a unified statistical framework synthesizing existing methods for sleep transition data analysis.
  • To enable robust comparisons between diseased and non-diseased subjects in epidemiological sleep studies.

Main Methods:

  • Development of Bayesian Poisson log-linear multilevel models incorporating hierarchical random effects.
  • Estimation and smoothing of non-parametric piecewise constant hazards to accommodate time-varying covariates.
  • Algebraic re-derivation of likelihood equivalence between Poisson regression with log(time) offset and survival regression.

Main Results:

  • The proposed models are scalable to large epidemiological studies, offering improved analysis of sleep transition rates.
  • The framework synthesizes stratified multi-state proportional hazards models and log-linear generalized estimating equations (GEE) models.
  • Demonstrated application using data from the Sleep Heart Health Study.

Conclusions:

  • Bayesian multilevel models offer a powerful and flexible approach for analyzing complex sleep transition data.
  • The developed methods enhance the ability to investigate population variability and disease-related differences in sleep patterns.
  • Reproducible analysis code and data are provided for further research.